Niki BioSolutions, Inc. Cost of Revenue
Niki BioSolutions, Inc. (NIKI) reported Cost of Revenue of $420.81 thousand for the 12-month period ending 2023-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-05-11
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2023-12-31 | $420.81K S-4/A · filed 2026-05-11 | |
| 2023-06-30 | $426.06K 6-K · filed 2024-12-20 | |
| 2022-12-31 | $1.22M 6-K · filed 2025-10-08 | |
| 2021-12-31 | $1.46M 20-F · filed 2024-04-30 |